Zobrazeno 1 - 10
of 798
pro vyhledávání: '"J. Mandrekar"'
Publikováno v:
Journal of Bone and Joint Infection, Vol 7, Pp 169-175 (2022)
Introduction: Staphylococcus aureus is the most common cause of orthopedic infections and can be challenging to treat, especially in the presence of a foreign body. The antistaphylococcal lysins exebacase and CF-296 have rapid bactericidal activity,
Externí odkaz:
https://doaj.org/article/58ac41028d92456381e13d30a57e2448
Autor:
David Zahrieh, Shauna L. Hillman, Angelina D. Tan, Jennifer L. Frank, Travis Dockter, Bobbi Jo Meyers, Cassie L. Cherevko, Elizabeth S. Peil, Shaylene McCue, Oudom Kour, Heather J. Gunn, Heather B. Neuman, George J. Chang, Electra D. Paskett, Sumithra J. Mandrekar, Amylou C. Dueck
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-13 (2022)
Abstract Introduction Alliance for Clinical Trials in Oncology (Alliance) coordinated trials utilize Medidata Rave® (Rave) as the primary clinical data capture system. A growing number of innovative and complex cancer care delivery research (CCDR) t
Externí odkaz:
https://doaj.org/article/4735ccaab1ad467b99542789d0367e53
Autor:
Jennifer G. Le-Rademacher, PhD, Elizabeth M. Storrick, BA, Aminah Jatoi, MD, Sumithra J. Mandrekar, PhD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 3, Iss 2, Pp 176-182 (2019)
Objectives: To report the results of a survey conducted among Mayo Clinic medical oncologists, hematologists, and cancer prevention specialists to better understand the current practice of determining whether an adverse event that a patient experienc
Externí odkaz:
https://doaj.org/article/ba08914ecf734c9ab22521d113e17415
Autor:
Joseph M. Unger, Michael LeBlanc, Suzanne George, Norman Wolmark, Walter J. Curran, Peter J. O'Dwyer, Mitchell D. Schnall, Robert S. Mannel, Sumithra J. Mandrekar, Robert J. Gray, Fengmin Zhao, Mariama Bah, Riha Vaidya, Charles D. Blanke
Publikováno v:
Journal of Clinical Oncology. 41:2020-2028
PURPOSE In the United States, the National Cancer Institute National Cancer Clinical Trials Network (NCTN) groups have conducted publicly funded oncology research for 50 years. The combined impact of all adult network group trials has never been syst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd04723984d939b9242b5459ee0768bb
https://doi.org/10.1200/jco.22.01826
https://doi.org/10.1200/jco.22.01826
Autor:
Amye J. Tevaarwerk, Elizabeth S. Harlos, Matthew J. Maurer, Heather L. VanBebber, Eli J. Misel, Sacha A. Nelson, Sara J. Holton, Abigail L. Stockham, Tufia C. Haddad, Steven R. Alberts, Robert R. McWilliams, Sumithra J. Mandrekar
Publikováno v:
Journal of the National Comprehensive Cancer Network. 21:QIM23-138
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::101c7ebef71ec37cdc740cb70a1873e3
https://doi.org/10.6004/jnccn.2022.7188
https://doi.org/10.6004/jnccn.2022.7188
Publikováno v:
Contemporary Clinical Trials Communications, Vol 17, Iss , Pp - (2020)
Purpose: Missing data commonly occur in cancer clinical trials (CCT) and may hinder the search for alternative trial endpoints. We consider reasons for missing tumor measurement (TM) data in CCT and how missing TM data are typically handled. We explo
Externí odkaz:
https://doaj.org/article/975608b1cfed44849fd35ce68d122996
Autor:
John C. Byrd, Amy S. Ruppert, Nyla A. Heerema, Alese E. Halvorson, Eva Hoke, Mitchell R. Smith, John E. Godwin, Stephen Couban, Todd A. Fehniger, Michael J. Thirman, Martin S. Tallman, Frederick R. Appelbaum, Richard M. Stone, Sue Robinson, Julie E. Chang, Sumithra J. Mandrekar, Richard A. Larson
Publikováno v:
Blood Advances, Vol 2, Iss 14, Pp 1705-1718 (2018)
Abstract: Prior to novel targeted agents for chronic lymphocytic leukemia (CLL), the best chemoimmunotherapy regimen in patients with non-del(11q) disease was unclear. The role of lenalidomide was also not defined. This phase 2 study randomized 342 u
Externí odkaz:
https://doaj.org/article/6202bf27c493461da18051facf6da22d
Autor:
Jeffrey M, Jacobson, David, Zahrieh, Carrie A, Strand, Marcia, Cruz-Correa, Surakit, Pungpapong, Lewis R, Roberts, Sumithra J, Mandrekar, Luz María, Rodriguez, Jean, Boyer, Idania, Marrero, Kimberly A, Kraynyak, Matthew P, Morrow, Albert J, Sylvester, Jan M, Pawlicki, Elisabeth, Gillespie, Eduardo, Barranco, Ellen, Richmond, Asad, Umar, David B, Weiner, Paul J, Limburg
Publikováno v:
Cancer Prevention Research. 16:163-173
Chronic hepatitis C can lead to cirrhosis and hepatocellular carcinoma. We studied the safety and immunogenicity of a novel therapeutic hepatitis C virus (HCV) genotype 1a/1b consensus DNA vaccine, INO-8000, encoding HCV NS3, NS4A, NS4B, and NS5A pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e22816b511314916d704c305f6aca562
https://doi.org/10.1158/1940-6207.capr-22-0217
https://doi.org/10.1158/1940-6207.capr-22-0217
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.